Skip to search boxSkip to navigationSkip to main content

Phase I clinical trial of donor t-helper type 2 cells after immunoablative, reduced intensity allogeneic PBSC transplant

  • Daniel Fowler(corresponding author)
    ,
  • J. Hou
    ,
  • J. Foley
    ,
  • F. Hakim
    ,
  • J. Odom
    ,
  • K. Castro
*Corresponding author for this work
  • National Institutes of Health
    ,
  • National Institutes of Health, Bethesda
    ,
  • University of Pennsylvania
Scholary Output:
Contribution to journal
Article
 Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 429-430 (2 pages)

Journal (Volume, Issue Number)

Cytotherapy (Volume 4, Issue 5)

Publication milestones

  • Published - 2002

Publication status

Published - 2002

ISSN

1465-3249

Publication IDs

  • Scopus: 18744415962
  • PubMed: 12473212

Access to documents

Publication metrics

Metrics

SciVal
FWCI
1.64
SciVal
Author count
16
SciVal
citations
18
SciVal
Paper percentile
68
Fractional count
1
Fractional count
0.06
Fractional count
15
Fractional count
0.94
Fractional count
1
Fractional count
1
Scopus
citations
18, opens in new tab

PlumX, opens in new tab

Citation count
19
Captures
5